Medifast (NYSE:MED – Get Free Report) issued an update on its second quarter 2024 earnings guidance on Monday morning. The company provided EPS guidance of 0.050-0.400 for the period, compared to the consensus EPS estimate of 0.780. The company issued revenue guidance of $150.0 million-$170.0 million, compared to the consensus revenue estimate of $168.9 million. […]
Medifast (NYSE:MED – Get Free Report) updated its second quarter earnings guidance on Monday. The company provided EPS guidance of $0.05-0.40 for the period, compared to the consensus EPS estimate of $0.68. The company issued revenue guidance of $150-170 million, compared to the consensus revenue estimate of $178.50 million. Medifast also updated its Q2 2024 […]
Denali Advisors LLC acquired a new position in shares of Medifast, Inc. (NYSE:MED – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 21,813 shares of the specialty retailer’s stock, valued at approximately $1,466,000. Denali Advisors LLC owned 0.20% […]
Medifast (NYSE:MED – Get Free Report) released its quarterly earnings results on Tuesday. The specialty retailer reported $1.09 EPS for the quarter, topping the consensus estimate of $0.99 by $0.10, Briefing.com reports. The company had revenue of $191.02 million during the quarter, compared to analyst estimates of $184.17 million. Medifast had a return on equity […]
Medifast (NYSE:MED – Get Free Report) released its quarterly earnings data on Tuesday. The specialty retailer reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.99 by $0.10, Briefing.com reports. The firm had revenue of $191.02 million for the quarter, compared to analyst estimates of $184.17 million. Medifast had a net […]